Zheng Zuo Selected Research

Kv1.2 Potassium Channel

1/2021

BmK86-P1, a New Degradation Peptide with Desirable Thermostability and Kv1.2 Channel-Specific Activity from Traditional Chinese Scorpion Medicinal Material.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Zuo Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 09/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 08/2019 - 07/2014
1	Stroke (Strokes) 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Ataxia (Dyssynergia) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Epilepsy (Aura) 01/2021
1	Body Weight (Weight, Body) 09/2019
1	Necrosis 09/2019
1	Ankylosing Spondylitis 10/2018
1	Kidney Diseases (Kidney Disease) 07/2014

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 09/2019 - 07/2014
1	4-toluenesulfonyl fluoride (TSF)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	SolutionsIBA 01/2021
1	Kv1.2 Potassium ChannelIBA 01/2021
1	CreatinineIBA 09/2019
1	Blood Proteins (Serum Proteins)IBA 09/2019
1	NitrogenIBA 09/2019
1	Urea (Carbamide)FDA LinkGeneric 09/2019
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2019
1	Connective Tissue Growth FactorIBA 08/2019
1	integrin-linked kinaseIBA 08/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 07/2014
1	Phosphorus (Red Phosphorus)IBA 07/2014

Therapy/Procedure

4	Moxibustion 01/2021 - 07/2014
1	Therapeutics 07/2014